Moors & Cabot’s Oracle ORCL Stock Holding History

Moors & Cabot’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Hold	–	-$3.6K	–	868
2023 Q2	–	Hold	–	–	–	831
2023 Q1	–	Hold	–	–	–	852

Other funds holding ORCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moors & Cabot's ORCL Position: Q1 2026 in Review

Moors & Cabot reduced its Oracle (ORCL) stake by 11% in Q1 2026, selling an estimated $924K and leaving 45,459 shares worth $6.69M. The position accounts for 0.29% of the portfolio, ranked #71.

Moors & Cabot first reported a position in ORCL in Q1 2014 and has held it in 49 quarters since. The position peaked at $10.4M in Q3 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

Moors & Cabot held 45,459 shares of Oracle worth $6.69M as of Q1 2026.
Moors & Cabot sold 5,684 Oracle shares in Q1 2026, an estimated $924K.
Oracle made up 0.29% of Moors & Cabot's portfolio in Q1 2026, its #71 holding.
Moors & Cabot first reported a position in Oracle in Q1 2014 and has held it in 49 quarters since.
Moors & Cabot's Oracle position peaked at $10.4M in Q3 2025.
3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.